OBJECTIVE: To evaluate whether the 4G/5G polymorphism of the plasminogen activator inhibitor 1 gene increases the risk of thromboembolic neurological complications, and, if so, whether these complications lengthen the period of mechanical ventilation and hospital stay. DESIGN: Prospective, case-control study in a 14 bed surgical intensive care unit of a university hospital. PATIENTS: 260 consecutive patients who underwent cardiac surgery with cardiopulmonary bypass and 111 controls. INTERVENTIONS: DNA was isolated and 4G/5G polymorphism was typed using RFLP methodology. MEASUREMENTS AND RESULTS: Genetic analysis revealed 4G/5G in 131 patients (50.4%), 5G/5G genotype in 82 (31.5%), and 4G/4G in only 47 (18.1%). Prevalence of neurological complications was 20.8% (n=54) (stroke 5.4%, n=14; encephalopathy 15.4%, n=40]. A trend towards higher risk of developing stroke (8.5% vs. 4.7%, RR 1.9) and a significant twofold increase in encephalopathy (27.7% vs. 12.7%; RR 2.6) was documented in 4G/4G carriers. Multivariate analysis showed that development of stroke or encephalopathy was independently associated with prolonged mechanical ventilation (OR 20), and that neurological complication (OR 2.4) and 4G/4G genotype (OR 2.6) were independently associated with hospital stay of 2 weeks or longer. CONCLUSIONS: The 4G/4G genotype can increase the risk of thromboembolic neurological complications after cardiac surgery with cardiopulmonary by-pass. The neurological complications result in longer time on ventilator and longer hospital stay.
OBJECTIVE: To evaluate whether the 4G/5G polymorphism of the plasminogen activator inhibitor 1 gene increases the risk of thromboembolic neurological complications, and, if so, whether these complications lengthen the period of mechanical ventilation and hospital stay. DESIGN: Prospective, case-control study in a 14 bed surgical intensive care unit of a university hospital. PATIENTS: 260 consecutive patients who underwent cardiac surgery with cardiopulmonary bypass and 111 controls. INTERVENTIONS: DNA was isolated and 4G/5G polymorphism was typed using RFLP methodology. MEASUREMENTS AND RESULTS: Genetic analysis revealed 4G/5G in 131 patients (50.4%), 5G/5G genotype in 82 (31.5%), and 4G/4G in only 47 (18.1%). Prevalence of neurological complications was 20.8% (n=54) (stroke 5.4%, n=14; encephalopathy 15.4%, n=40]. A trend towards higher risk of developing stroke (8.5% vs. 4.7%, RR 1.9) and a significant twofold increase in encephalopathy (27.7% vs. 12.7%; RR 2.6) was documented in 4G/4G carriers. Multivariate analysis showed that development of stroke or encephalopathy was independently associated with prolonged mechanical ventilation (OR 20), and that neurological complication (OR 2.4) and 4G/4G genotype (OR 2.6) were independently associated with hospital stay of 2 weeks or longer. CONCLUSIONS: The 4G/4G genotype can increase the risk of thromboembolic neurological complications after cardiac surgery with cardiopulmonary by-pass. The neurological complications result in longer time on ventilator and longer hospital stay.
Authors: F Burzotta; A Di Castelnuovo; C Amore; A D'Orazio; R Di Bitondo; M B Donati; L Iacoviello Journal: Thromb Haemost Date: 1998-02 Impact factor: 5.249
Authors: Antonio Maria Calafiore; Michele Di Mauro; Carlo Canosa; Gabriele Di Giammarco; Angela Lorena Iaco; Marco Contini Journal: Eur J Cardiothorac Surg Date: 2003-03 Impact factor: 4.191
Authors: R L Wolman; N A Nussmeier; A Aggarwal; M S Kanchuger; G W Roach; M F Newman; C M Mangano; K E Marschall; C Ley; D M Boisvert; G M Ozanne; A Herskowitz; S H Graham; D T Mangano Journal: Stroke Date: 1999-03 Impact factor: 7.914
Authors: Marco Ranucci; Alessandro Frigiola; Lorenzo Menicanti; Antonio Ditta; Alessandra Boncilli; Simonetta Brozzi Journal: Crit Care Med Date: 2005-02 Impact factor: 7.598
Authors: M A Borger; J Ivanov; R D Weisel; C M Peniston; L L Mickleborough; G Rambaldini; G Cohen; V Rao; C M Feindel; T E David Journal: Circulation Date: 1998-11-10 Impact factor: 29.690
Authors: Peter Andrews; Elie Azoulay; Massimo Antonelli; Laurent Brochard; Christian Brun-Buisson; Daniel De Backer; Geoffrey Dobb; Jean-Yves Fagon; Herwig Gerlach; Johan Groeneveld; Duncan Macrae; Jordi Mancebo; Philipp Metnitz; Stefano Nava; Jerôme Pugin; Michael Pinsky; Peter Radermacher; Christian Richard Journal: Intensive Care Med Date: 2006-12-19 Impact factor: 17.440
Authors: Adriano de Paula Sabino; Daniel Dias Ribeiro; Caroline Pereira Domingueti; Mariana Silva Dos Santos; Telma Gadelha; Luci Maria Santana Dusse; Maria das Graças Carvalho; Ana Paula Fernandes Journal: Mol Biol Rep Date: 2011-03-04 Impact factor: 2.316